Spearheading CRISPR/Cas9 Screening to Identity Genes Necessary for LSD1 to Maintain the Neuroendocrine Identify of Small Cell Lung Cancer
Time: 3:15 pm
day: Day One
Details:
- Leveraging genome-wide CRISPR/Cas9 screening to identify key targets of LSD1
- Identifying key regulators of neuroendocrine cell state
- Highlighting cell state plasticity to unmask immunogenicity
Matthew Oser" alt="Matthew Oser" itemprop="image">